ZA948005B - Novel polypeptide and anti-HIV agent prepared therefrom - Google Patents

Novel polypeptide and anti-HIV agent prepared therefrom

Info

Publication number
ZA948005B
ZA948005B ZA948005A ZA948005A ZA948005B ZA 948005 B ZA948005 B ZA 948005B ZA 948005 A ZA948005 A ZA 948005A ZA 948005 A ZA948005 A ZA 948005A ZA 948005 B ZA948005 B ZA 948005B
Authority
ZA
South Africa
Prior art keywords
pct
polypeptide
hiv agent
prepared therefrom
agent prepared
Prior art date
Application number
ZA948005A
Other languages
English (en)
Inventor
Akiyoshi Matsumoto
Michinori Waki
Original Assignee
Seikagaku Corporation
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Seikagaku Corporation filed Critical Seikagaku Corporation
Publication of ZA948005B publication Critical patent/ZA948005B/xx

Links

Classifications

    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07KPEPTIDES
    • C07K7/00Peptides having 5 to 20 amino acids in a fully defined sequence; Derivatives thereof
    • C07K7/04Linear peptides containing only normal peptide links
    • C07K7/08Linear peptides containing only normal peptide links having 12 to 20 amino acids
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/12Antivirals
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/12Antivirals
    • A61P31/14Antivirals for RNA viruses
    • A61P31/18Antivirals for RNA viruses for HIV
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00Medicinal preparations containing peptides

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Organic Chemistry (AREA)
  • General Health & Medical Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Molecular Biology (AREA)
  • Virology (AREA)
  • Communicable Diseases (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Genetics & Genomics (AREA)
  • Biophysics (AREA)
  • Biochemistry (AREA)
  • Oncology (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Animal Behavior & Ethology (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • AIDS & HIV (AREA)
  • Tropical Medicine & Parasitology (AREA)
  • Peptides Or Proteins (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Medicines Containing Antibodies Or Antigens For Use As Internal Diagnostic Agents (AREA)
ZA948005A 1993-10-14 1994-10-13 Novel polypeptide and anti-HIV agent prepared therefrom ZA948005B (en)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
JP28034693 1993-10-14

Publications (1)

Publication Number Publication Date
ZA948005B true ZA948005B (en) 1996-02-06

Family

ID=17623732

Family Applications (1)

Application Number Title Priority Date Filing Date
ZA948005A ZA948005B (en) 1993-10-14 1994-10-13 Novel polypeptide and anti-HIV agent prepared therefrom

Country Status (17)

Country Link
US (1) US5776899A (de)
EP (1) EP0677061B1 (de)
JP (1) JPH08504837A (de)
KR (1) KR100208873B1 (de)
CN (1) CN1038841C (de)
AT (1) ATE177114T1 (de)
AU (1) AU682405B2 (de)
CA (1) CA2151283A1 (de)
CZ (1) CZ287239B6 (de)
DE (1) DE69416824T2 (de)
FI (1) FI952900A0 (de)
HU (1) HU217442B (de)
NO (1) NO952321L (de)
NZ (1) NZ274560A (de)
RU (1) RU2136696C1 (de)
WO (1) WO1995010534A1 (de)
ZA (1) ZA948005B (de)

Families Citing this family (37)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5804558A (en) * 1993-07-20 1998-09-08 University Of California Protegrins
US6653442B1 (en) 1993-07-20 2003-11-25 Intrabiotics Pharmaceuticals, Inc. Protegrins
US5693486A (en) * 1993-07-20 1997-12-02 Intrabiotics DNA sequences encoding protegrins and protegrin analogs and their use in recombinant methods of producing protegrins
US5708145A (en) * 1993-07-20 1998-01-13 University Of California Immunglobulins reactive with protegrins
US6025326A (en) * 1995-07-07 2000-02-15 Intrabiotics Pharmaceuticals, Inc. Compositions and methods for the prevention and treatment of oral mucositis
US5994306A (en) * 1995-11-22 1999-11-30 Intrabiotics Pharmaceuticals, Inc. Fine-tuned protegrins
US5916872A (en) * 1996-07-24 1999-06-29 Intrabiotics Pharmaceuticals, Inc. Cyclic peptides having broad spectrum antimicrobial activity
CA2268011A1 (en) 1996-10-15 1998-04-23 Seikagaku Corporation Polypeptide transition metal salts and method of enhancing anti-hiv activity of polypeptide
AU6518698A (en) * 1997-03-28 1998-10-22 Seikagaku Corporation Novel anti-hiv complexes and medicinal compositions
MXPA02001349A (es) * 1999-08-09 2002-07-22 Tripep Ab Inhibidores de la polimerizacion de proteinas y metodos de uso.
US6337317B1 (en) 2000-06-27 2002-01-08 The University Of British Columbia Antimicrobial peptides and methods of use thereof
US8435939B2 (en) 2000-09-05 2013-05-07 Biokine Therapeutics Ltd. Polypeptide anti-HIV agent containing the same
AU2001284419A1 (en) 2000-09-05 2002-03-22 Seikagaku Corporation Novel polypeptides and anti-hiv drugs containing the same
US6593455B2 (en) * 2001-08-24 2003-07-15 Tripep Ab Tripeptide amides that block viral infectivity and methods of use thereof
EP1436317A1 (de) * 2001-09-19 2004-07-14 Tripep Ab Moleküle, die die virale infektivität hemmen, und verfahren zu deren anwendung
KR100932520B1 (ko) * 2002-10-31 2009-12-17 박래옥 항암제 조성물
JP4781621B2 (ja) * 2002-08-27 2011-09-28 バイオカイン セラピューティックス リミテッド Cxcr4拮抗薬およびその用途
EP2426139B1 (de) 2002-08-27 2014-10-01 Biokine Therapeutics Ltd. CXCR4-Antagonisten und Verwendung davon
CN1708310A (zh) * 2002-10-31 2005-12-14 朴来玉 抗癌或抗病毒组合物
US20040132642A1 (en) * 2002-11-12 2004-07-08 Government Of The U.S.A., Represented By The Secretary, Dept. Of Health & Human Services Methods of inhibiting metastasis or growth of a tumor cell
US20050096319A1 (en) * 2003-02-21 2005-05-05 Balzarini Jan M.R. Identification of compounds that inhibit replication of human immunodeficiency virus
NZ541883A (en) * 2003-02-21 2008-12-24 Tripep Ab Glycinamide derivative for inhibiting HIV replication
AU2003232253A1 (en) 2003-05-02 2004-11-23 Polyphor Ag Template-fixed beta-hairpin peptidomimetics with cxcr4 antagonizing activity
KR20080106467A (ko) 2006-03-10 2008-12-05 펩트셀 리미티드 Hiv 조절 또는 보조 단백질의 펩타이드, 그 조성물 및 이용 방법
CN100366633C (zh) * 2006-04-18 2008-02-06 河北师范大学 棕点湍蛙抗病毒多肽及其在制药中的应用
US20100184694A1 (en) 2006-12-21 2010-07-22 Biokine Therapeutics Ltd. T-140 peptide analogs having cxcr4 super-agonist activity for cancer therapy
US9271933B2 (en) * 2007-11-27 2016-03-01 Rutgers, The State University Of New Jersey Graft copolymer polyelectrolyte complexes for drug delivery
US9789194B2 (en) 2007-11-27 2017-10-17 Rutgers, The State University Of New Jersey Graft copolymer polyelectrolyte complexes for drug delivery
WO2010027818A2 (en) 2008-08-25 2010-03-11 Dana-Farber Cancer Institute, Inc. Conserved hemagglutinin epitope, antibodies to the epitope, and methods of use
MX2011013459A (es) 2009-06-14 2012-05-08 Biokine Therapeutics Ltd Terapia de peptido para incrementar los niveles de plaquetas.
ES2552944T3 (es) 2011-06-07 2015-12-03 Polyphor Ag Peptidomiméticos de horquilla beta como antagonistas de CXCR4
WO2013160895A1 (en) 2012-04-24 2013-10-31 Biokine Therapeutics Ltd. Peptides and use thereof in the treatment of large cell lung cancer
CN104072579B (zh) * 2014-06-11 2017-01-25 南方医科大学 具有抗菌抗病毒活性的小分子肽及其活性修饰物
US10682390B2 (en) 2015-07-16 2020-06-16 Biokine Therapeutics Ltd. Compositions and methods for treating cancer
EP3419645B1 (de) 2016-02-23 2020-09-02 BioLineRx Ltd. Verfahren zur festlegung eines behandlungsplans für akute myeloische leukämie
RU2658781C1 (ru) * 2017-12-28 2018-06-22 Федеральное государственное бюджетное учреждение науки институт биоорганической химии им. академиков М.М. Шемякина и Ю.А. Овчинникова Российской академии наук (ИБХ РАН) Пептид, обладающий противоопухолевой активностью
CN110841607B (zh) * 2019-11-22 2020-07-24 中国科学院地质与地球物理研究所 一种超低本底金特效树脂及其制备和应用

Family Cites Families (8)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CA1337781C (en) * 1987-08-21 1995-12-19 Takanori Nakamura Polypeptide from horseshoe crab exhibiting affinity for lipopolysaccharide and method of preparation
JP2641744B2 (ja) * 1988-08-18 1997-08-20 マルハ株式会社 新規ペプチド及び抗菌剤
JP2641742B2 (ja) * 1988-08-18 1997-08-20 マルハ株式会社 新規ペプチド及び抗菌剤
JP2798711B2 (ja) * 1988-09-26 1998-09-17 生化学工業株式会社 ポリペプチド系抗ウィルス剤
BR9105902A (pt) * 1990-09-11 1994-06-28 Seikagaku Kogyo Co Ltd Novo polipeptídeo
HUT61036A (en) * 1991-05-02 1992-11-30 Seikagaku Kogyo Co Ltd Process for producing new polypeptides capable of linking to lipopolysaccharides and pharmaceutical compositions comprising same as active ingredients
JP3266311B2 (ja) * 1991-05-02 2002-03-18 生化学工業株式会社 新規ポリペプチドおよびこれを用いる抗hiv剤
JP2500194B2 (ja) 1993-08-10 1996-05-29 株式会社ヴァンドームヤマダ 商品発注システム

Also Published As

Publication number Publication date
RU95112539A (ru) 1997-06-27
NO952321D0 (no) 1995-06-13
FI952900A (fi) 1995-06-13
FI952900A0 (fi) 1995-06-13
EP0677061A1 (de) 1995-10-18
NZ274560A (en) 1998-03-25
HU9501719D0 (en) 1995-08-28
AU7862894A (en) 1995-05-04
HU217442B (hu) 2000-01-28
CZ153395A3 (en) 1995-12-13
CN1038841C (zh) 1998-06-24
HUT72974A (en) 1996-06-28
US5776899A (en) 1998-07-07
JPH08504837A (ja) 1996-05-28
CA2151283A1 (en) 1995-04-20
KR100208873B1 (ko) 1999-07-15
ATE177114T1 (de) 1999-03-15
NO952321L (no) 1995-08-09
RU2136696C1 (ru) 1999-09-10
CN1116427A (zh) 1996-02-07
WO1995010534A1 (en) 1995-04-20
EP0677061B1 (de) 1999-03-03
DE69416824D1 (de) 1999-04-08
DE69416824T2 (de) 1999-07-08
AU682405B2 (en) 1997-10-02
CZ287239B6 (en) 2000-10-11

Similar Documents

Publication Publication Date Title
ZA948005B (en) Novel polypeptide and anti-HIV agent prepared therefrom
IL111077A (en) Pyridine derivatives processes for the preparation thereof and pharmaceutical compositions containing them
IL111861A (en) Phenyl-n-substituted azabicycloalkene derivatives and pharmaceutical compositions containing them
AU645709B2 (en) New 2,4-thiazolidinedione compounds, process for preparing them and pharmaceutical compositions containing them
IL108520A0 (en) Imidazopyridine derivatives, processes for the preparation thereof, and pharmaceutical compositions containing them
HUT74937A (en) Substituted azadioxacycloalkenes and use of them as
ZA948670B (en) New benzoyl guanidine derivatives,the preparation thereof and their use in pharmaceutical compositions
HUT71584A (en) Lipopeptide derivatives and pharmaceutical compositions containing them
IL98133A0 (en) Sulphonyl substituted benzo-naphthyridine derivatives,processes for the preparation thereof and pharmaceutical compositions containing the same
AU7575394A (en) Substituted 1-naphthyl-3-pyrazolecarboxamides which are active on neurotensin, their preparation and pharmaceutical compositions containing them
CA2056421A1 (en) Agent against autoimmune diseases
ZA949593B (en) N-substituted azabicycloheptane derivatives their preparation and use
TW261614B (de)
IL108288A0 (en) Pyrrolidine derivatives, their preparation and medicaments containing them
IL107520A0 (en) Substituted ortho-ethenylphenylacetic acid derivatives and pharmaceutical compositions containing them
TW259787B (de)
TW261605B (de)
SI0805817T1 (de)
AU1067295A (en) Substituted aminoalkylaminopyridines
IL107917A0 (en) Triazoloquinazolines, their preparation and their use as medicaments
JO1711B1 (en) Therapeutic agents